Beruflich Dokumente
Kultur Dokumente
Review
a r t i c l e
i n f o
a b s t r a c t
Keywords:
Adiposity
Ingestive behavior
Obesity
Food intake
Bisphenol A
Diethylstilbestrol
The prevalence of adult obesity has risen markedly in the last quarter of the 20th century and has not been
reversed in this century. Less well known is the fact that obesity prevalence has risen in domestic, laboratory,
and feral animals, suggesting that all of these species have been exposed to obesogenic factors present in the
environment. This review emphasizes interactions among three biological processes known to inuence energy
balance: Sexual differentiation, endocrine disruption, and maternal programming. Sexual dimorphisms include
differences between males and females in body weight, adiposity, adipose tissue distribution, ingestive behavior,
and the underlying neural circuits. These sexual dimorphisms are controlled by sex chromosomes, hormones that
masculinize or feminize adult body weight during perinatal development, and hormones that act during later
periods of development, such as puberty. Endocrine disruptors are natural and synthetic molecules that attenuate or block normal hormonal action during these same developmental periods. A growing body of research
documents effects of endocrine disruptors on the differentiation of adipocytes and the central nervous system
circuits that control food intake, energy expenditure, and adipose tissue storage. In parallel, interest has grown
in epigenetic inuences, including maternal programming, the process by which the mother's experience has
permanent effects on energy-balancing traits in the offspring. This review highlights the points at which maternal
programming, sexual differentiation, and endocrine disruption might dovetail to inuence global changes in
energy balancing traits.
2014 Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by/3.0/).
Contents
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Genes, poor diet, and sedentary behavior cannot explain obesity . . . . .
Introduction to endocrine disruptors . . . . . . . . . . . . . . . . .
Endocrine disruptors, ingestive behavior, energy balance, and obesity . . .
Sexual dimorphisms of the energy balancing traits . . . . . . . . . . .
Sex chromosomes and energy balance . . . . . . . . . . . . . . . . .
The organizational hypothesis and energy balance . . . . . . . . . . .
The aromatization hypothesis, multiple critical periods, and energy balance
Endocrine disruptors, sexual differentiation, brain, and behavior . . . . .
Endocrine disruptors, sexual differentiation, and peripheral factors . . . .
Linking peripheral metabolism to brain and behavior . . . . . . . . . .
Maternal programming of adult energy balancing traits . . . . . . . . .
Epigenetics and transgenerational effects on energy balance . . . . . . .
Summary, conclusions, and future directions . . . . . . . . . . . . . .
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . .
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Corresponding author at: Department of Biological Sciences, 111 Research Drive, Bethlehem, PA 18015, USA. Fax: +1 610 758 4004.
E-mail address: js0v@lehigh.edu (J.E. Schneider).
http://dx.doi.org/10.1016/j.yhbeh.2014.03.011
0018-506X/ 2014 Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by/3.0/).
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
105
105
106
106
107
108
109
109
110
111
112
112
113
115
115
115
Introduction
A global rise in the incidence of adult obesity has occurred over the
past 150 years, with a slow and steady increase prior to 1970 and a
sharp rise between the years 1970 and 2000 (Bundred et al., 2001;
Flegal et al., 1998, 2002, 2010; Ogden et al., 1997, 2006, 2007). In spite
of well publicized government guidelines, medical advice, and a proliferation of diet books, weight-watcher's programs, prescription diet
pills, fat-burning herbs, and appetite suppressing supplements
(Taubes, 2007), the prevalence of obesity remains high. Despite recent
reports by the news media that childhood obesity has decreased significantly in the last decade (e.g., Tavernise, 2014), the Centers for Disease
Control and Prevention (CDC) concludes that Overall, there have been
no signicant changes in obesity prevalence in youth or adults between
20032004 and 20112012. Obesity prevalence remains high and thus
it is important to continue surveillance. This quote is from the same
CDC report that provoked the optimistic news media headlines about
the putative decrease in childhood obesity (Ogden et al., 2014). Thus,
more than a decade into the 21st century, the high incidence of obesity
has not reversed (Ogden et al., 2013, 2014).
The relatively rapid rate of increase in body weight and the failure to
reverse the high incidence of obesity present a challenging puzzle with
many missing pieces. Some of the important pieces of this puzzle are in
place, whereas others have yet to be fully appreciated and integrated
with the other pieces.
For many years, the focus has been on three factors: Genetic inuences, diet, and sedentary behavior. This review will emphasize three
overlapping biological processes that interact with these factors: Sexual
differentiation, maternal programming, and endocrine disruption. We
begin with a very brief review of the role of genes, diet, and exercise,
noting that global obesity patterns are not explained by these factors
alone. Other evidence suggests the existence of widespread environmental obesogen acting on humans, laboratory rodents and nonhuman
primates, domestic animals, and even feral animals. We therefore
discuss endocrine disrupting compounds, natural and synthetic molecules from the environment that interfere with endocrine processes, including energy balance and ingestive behavior (Auwerx, 1999). A clear
understanding of their mechanism of action, however, requires that we
understand sex differences in energy-balancing systems. In most species including our own, males differ from females in many energybalancing characteristics. Some of these sexual dimorphisms are behavioral in that they involve caloric intake, diet preferences, the rewarding
aspects of food, and central nervous system circuits that control these
behaviors. Other sexual dimorphisms are morphological and physiological; they involve the distribution of adipose tissue, adipocyte differentiation, glucose homeostasis, and other peripheral systems. We discuss
the signicance of these sex differences and the importance of understanding how these differences come about. This brings us to the process of sexual differentiation, the process whereby physiological traits
are either masculinized or feminized by sex chromosomes, hormones
secreted perinatally, hormones secreted during other critical periods
of development (e.g., puberty), and interactions among these factors.
Reproductive biologists have dened multiple mechanisms involved
in sexual differentiation and experimental designs that discriminate
among them, but few have been employed in obesity research. Some
of these mechanisms involve fetal steroid receptor action, and endocrine disruptors act on these same receptors. Thus, experimental approaches used in sexual differentiation research will be critical in
understanding the effects of endocrine disruptors on obesity.
Using a few well-designed studies as examples, we connect four new
pieces of the obesity puzzle. First, endocrine disruptors are ubiquitous in
the environment (Baillie-Hamilton, 2002; Colborn et al., 1993;
Simonich and Hites, 1995). Second, they affect energy balancing systems (Heindel, 2003; Mackay et al., 2013; Manikkam et al., 2013;
Newbold et al., 2005; Oken and Gillman, 2003; Ruhlen et al., 2008;
Skinner et al., 2013; Tracey et al., 2013; Vom Saal et al., 2012). Third,
105
106
Phthalates
ER
DDT
GH
GHR
ER !
AR
ER
GR
FFAs
Lukotrienes
Prostaglandins
PPAR
RXR
TBTs
high dose
Fig. 1. A diagram of a hypothetical cell illustrating loci where endocrine disruptors (from
outside the cell membrane) interfere with processes within the cell.
Adapted from Grun and Blumberg (2007).
safe to assume that these nonhuman animals are not victims of corporate marketing. Furthermore, the rises in obesity include laboratory
animals fed the control diets that formerly did not support current
rates of body weight gain. It might be argued that pet and lab animal
obesity is accounted for by a sedentary existence in small, conned
spaces. This, however, does not explain the next piece of the puzzle:
obesity in wildlife. Recent data have emerged documenting obesity in
feral animals that are not conned to cages or homes, but are free to
roam (Klimentidis et al., 2011; Wingeld, 2008). This suggests that
there might be agents in the environment that have widespread
obesogenic effects on many different species.
Introduction to endocrine disruptors
The book Our Stolen Future brought world-wide attention to the fact
that many natural and synthetic molecules interfere with endocrine
processes acting as toxins to animals that come in contact with them
(Colborn et al., 1997). These endocrine-disrupting compounds typically
bind to hormone receptors, thereby mimicking or blocking hormone
action. The best-known example might be the devastating effects
of DDT (dichlorodiphenyltrichloroethane) on populations of bald
eagles (Bowerman et al., 1995; Colborn, 1991). In this case, a synthetic
molecule from a commonly used pesticide caused a rapid decline in
reproductive success, largely by mimicking the action of estrogens
binding to estrogen receptors (ERs). After four decades of study, it is
clear that there are many different endocrine disruptors that interfere
with estrogen, androgen, thyroid, or glucocorticoid action, with related
effects on steroid biosynthesis, steroid sensitive neurotransmitter
systems, hormone degradation and/or elimination, reproductive
development, and behavior (Fig. 1, reviewed by Gore, 2008). Estrogenic
compounds include polychlorinated biphenyls (PCBs), components of
coolants, insulators, plasticizers and ame-retardants. Similarly,
phytoestrogens such as genistein, pesticides like DDT, and compounds
that leech from plastic containers such as bisphenol A (BPA) are estrogenic. Phthalates, used as plasticizers, tend to be androgen receptor
(AR) antagonists, although some are clearly estrogenic. These are just
a few of many examples. Effects of endocrine disruptors on the mammalian reproductive system include but are not limited to inhibited
spermatogenesis and ovulation, cryptorchidism, hypospadias, decreased semen quality, premature ovarian failure, polycystic ovary syndrome (PCOS), endometriosis, accelerated puberty, masculinized
genitalia in genetic females, feminized yolk production (vitellogenesis)
2008; Sakurai et al., 2004). The variety of effects and mechanism of action
on energy balance are as varied as those on reproduction.
The effects of endocrine disruptors differ with different stages of
development. The most pronounced effects, at the lowest concentrations, occur during fetal development, when endocrine disruptors
make permanent changes that determine adult physiological and
behavioral function. Endocrine disruptors cross the placenta, i.e., they
are transferred across the fetalmaternal blood barrier and are present
in breast milk (Alleva et al., 1998; Bordet et al., 1993; Jacobson and
Jacobson, 1996). In some cases, transient exposure to endocrinedisrupting compounds during fetal development affects reproductive
traits in adults, which persists and leads to obesity in successive (e.g.,
the F3) generations, even though the endocrine-disrupting compound
is no longer present in the environment (Manikkam et al., 2013;
Skinner et al., 2013; Tracey et al., 2013).
Perinatal effects of endocrine disruptors are likely to interfere with
key steps in the development of sex differences. Endocrine disruptor
action involves the perinatal action of androgens, estrogens, and
glucocorticoids on their cognate receptors. Understanding the natural
process of sexual differentiation has been key to understanding the
effects of endocrine disruptors on development of the sexually dimorphic reproductive system. Because energy-balancing traits are sexually
dimorphic, understanding sexual differentiation is likely to be critical
for understanding endocrine disruptor effects on energy balance.
Sexual dimorphisms of the energy balancing traits
Sexual dimorphisms in energy balance are not just an interesting
aside or incidental tangent to the study of energy balance. Sexual differentiation is an essential puzzle piece that must be integrated into the
bigger picture of energy balance. We have known about sex differences
in body composition since the beginning of behavioral endocrinology
(Berthold, 1849), and we know that these differences are in part due
to the effects of testicular androgens on body fat storage and muscle development (Pasquali, 2006; Siegel et al., 1981; Symeon et al., 2010).
These effects, however, are not explained by activational effects of
adult hormones in all species. For example, in cattle, it is clear that
peripubertal androgens increase growth and muscle development
(Tucker and Merkel, 1987), yet castrated bulls (steers) grow faster
than adult females (heifers), and there are species differences in the
sexual dimorphism. The adult presence of androgens vs. estrogens
cannot explain these phenomena. These sexual dimorphisms in growth
and morphology are of great interest in the meat and dairy industry, and
have revealed a plethora of sexual dimorphisms, such as those found
in growth hormone concentrations, insulin-like growth factor, and
somatotrophin release-inhibitory factor (reviewed by Gatford et al.,
1998). Sexual dimorphisms and their link to reproductive success will
be central to understanding the difference between healthy energy balance and unhealthy energy balance.
Androgens, adiposity, and disease are interrelated, particularly in
humans. Men, on average have higher circulating androgen concentrations and are larger than women. What is more important, they tend
to accumulate white adipose tissue (WAT) in the visceral, abdominal
region, whereas women tend to accumulate WAT subcutaneously, particularly in the gluteofemoral region, i.e., the hips and thighs (Kotani
et al., 1994). This is reected in the waist-to-hip ratio, which is signicantly higher in men than in women. Male-typical (android) but not
female-typical (gynoid) WAT distribution is linked to many negative
health consequences (Wajchenberg, 2000), even in the absence of
obesity, including insulin and leptin resistance (Bonora, 2000; Lemieux,
2001; Macotela et al., 2009), type II diabetes (Lundgren et al., 1989),
cardiovascular disease (Kissebah et al., 1982; Krotkiewski et al., 1983),
hypertension (van Lenthe et al., 1998), and inammation (Lemieux
et al., 2001). The gynoid WAT distribution is not associated with these
negative health consequences. This is partially because subcutaneous
WAT, more prevalent in females, has a very different cytoarchitecture
107
108
XX
XY
No Sry
Sry
Ovary
Testis
*
*
*
*
*
Feminized and
demasculinized
ingestive behavior and
WAT distribution
Masculinized and
defeminized ingestive
behavior and WAT
distribution
Fig. 2. A diagram of the steps of sexual differentiation, illustrating the steps where endocrine disruptors are known to interfere. Points of endocrine disruption are noted with an asterisk.
the sexual differentiation of energy balancing traits with the same rigor
that we examine sexual differentiation of reproductive traits.
Furthermore, these data pique a number of important questions.
Which came rst, the unmanageable appetite and overeating, the increased visceral WAT accumulation, or the decreased energy expenditure? Are these effects rooted in the origins of sex differences? Are
these traits also inuenced by endocrine disruptors?
Sex chromosomes and energy balance
Investigators interested in the origins of obesity will be aided by
a better understanding of the process of sexual differentiation
(Fig. 2). Sex differences arise by genetic, hormonal, and environmental
effects and the interaction among these factors (reviewed by Lenz
et al., 2012).
The initial steps are related to the presence or absence of genes on
the Y chromosome. The undifferentiated genital ridge, for example,
develops into the testis in the presence of the Sry gene and into the
ovary in its absence. Aspects of body weight and energy metabolism
109
110
supplemented diets. Female rats that are not obesity-prone are resistant
to the hyperphagia and weight gain induced by the saccharin supplement (Swithers et al., 2013a). Adult ovariectomy fails to ameliorate
the sex difference in resistance to hyperphagia in response to the
high-intensity sweetener. However, the sex difference is abolished by
adult treatment with aromatase, suggesting that the normal, obesityresistant female is actively feminized by local estrogen action. There
might also be some pubertal programming of the response to highintensity sweeteners because when the ovaries are surgically removed
prior to the onset of puberty, females are masculinized; i.e., females are
not resistant to obesity and overeating induced by the high-intensity
sweetener (Swithers et al., 2013a). The results suggest that the female
tendency to be resistant to the obesogenic effects of high-intensity sweeteners is actively feminized peripubertally and involves the conversion of
testosterone to estradiol in localized cells in adulthood (Fig. 2).
Endocrine disruptors, sexual differentiation, brain, and behavior
Since the classic experiments on the prenatal organization of body
weight and food intake in the 60s and 70s, many sex differences in
ingestive behavior have been noted, yet relatively few of these have
been traced to organizational effects. Even fewer have been examined
with reference to perinatal aromatization, synaptocrine action, or active
feminization.
Recent attention has turned to the effects of perinatal gonadal
steroids on the neural circuitry of ingestive behavior. Male mice have
a signicantly higher daily food intake than female mice throughout
life. In addition, they show higher levels of postfast hyperphagia and a
higher sensitivity to leptin-induced hypophagia compared to female
mice (Nohara et al., 2011), and these behavioral sex differences have
been linked to sexual dimorphisms in the arcuate nucleus of the hypothalamus (ARH).
The ARH has received a great deal of attention as a primary controller
of ingestive behavior in response to metabolic fuel availability, insulin,
leptin, and ghrelin (reviewed by Barsh and Schwartz, 2002; Crowley
et al., 2001; Schwartz and Porte, 2005; Zigman and Elmquist, 2003).
Despite this intense focus, it should be mentioned that ingestive behavior is known to be controlled by a distributed neural network that
includes peripheral sensors of metabolic fuel availability and nutrient
intake, the caudal brain stem, midbrain, hypothalamus, and other
areas including the nucleus accumbens, ventral tegmental area, and
amygdala (reviewed by Grill, 2010; Grill and Hayes, 2009). In the
ARH, however orexigenic effects of neuropeptide Y (NPY) and agoutirelated protein (AgRP) are thought to be counterbalanced by the anorectic peptides: cocaine and amphetamine-regulated transcript
(CART) and alpha-melanocyte-stimulating hormone (-MSH), a cleavage product of the proopiomelanocortin (POMC) gene. Metabolic challenges tend to increase NPY and AgRP gene expression and secretion
while simultaneously decreasing these parameters in POMC cells.
These changes can be reversed by re-feeding or by treatment with the
adipocyte hormone leptin (reviewed by Schwartz and Porte, 2005;
Zigman and Elmquist, 2003). Peripheral hormones affect not only the release of neuropeptides but also the synaptic input into NPY/AgRP and
POMC/CART cells (reviewed by Briggs and Andrews, 2011; Eckel, 2011;
Gao et al., 2007; Gyengesi et al., 2010; Zigman and Elmquist, 2003).
Relevant to the topic at hand, there is a sexual dimorphism in the
number of ARH cells that contain NPY, AgRP, and POMC (Nohara et al.,
2011). Male rats show signicantly lower POMC gene expression and
neuronal projections from POMC cells to the ARH compared to females.
Perinatal androgens masculinize the sexually dimorphic circuits of the
ARH. The daily food intake, postfast hyperphagia, and POMC gene expression and projections are fully masculinized in females treated with
either testosterone or dihydrotestosterone (DHT), both of which act via
the ARs. This is consistent with the organizational hypothesis, the idea
that testosterone masculinizes the energy balancing system during
early development via action on AR in the ARH (Nohara et al., 2011).
111
112
that encode putative orexigenic and anorectic peptides, increased circulating cortisol concentrations, and increased proinammatory signals.
Furthermore, as adults the offspring develop preferences for high fat
diets (reviewed by Wilson et al., 2014). Furthermore, the obesity of offspring of overnourished mothers can inuence the subsequent generations (Lumey and Stein, 1997; Sullivan et al., 2014; Taylor and Poston,
2007). It might seem paradoxical that both undernutrition and overnutrition have a similar effect on offspring. This is less surprising when we
remember that some organisms that are predisposed to excess lipogenesis also experience a decit in the availability of oxidizable fuels that
can lead to overeating. As explained earlier in this review (see the section on "Linking peripheral metabolism to brain and behavior), having
an abundance of adipose tissue and lipids stored inside adipocytes is
not the same as having an abundance of oxidizable fuels readily available for cellular work.
This line of research is promising, yet, we seem to have lost sight of
the original nding in rats (Jones and Friedman, 1982), which included
a profound sex difference: The susceptibility to diet-induced obesity in
rats occurred mainly in the male pups of mothers food restricted during
the rst two weeks of pregnancy, whereas in female pups, there were
changes in adipocyte architecture but not in the propensity for dietinduced obesity. This suggests that the eld of maternal programming
must meld with the study of sexual differentiation.
In fact, adult exposure to a calorically-dense diet in adulthood, perinatal androgen exposure, and maternal undernutrition all have similar
effects on cardiovascular health embodied by what is referred to as
the metabolic syndrome; all three produce enlarged mesenteric
adipocytes, an atherogenic lipid prole, insulin resistance, hyperglycemia, and a predisposition to overeat a calorically-dense diet (Demissie
et al., 2008; Manikkam et al., 2004). Furthermore, maternal energy
balance and prenatal testosterone interact to amplify the masculinization of the luteinizing hormone-surge system (Steckler et al., 2009).
Thus, it is important to ask whether maternal energy availability interacts with prenatal hormones to change adult energy balance.
Understanding the mechanisms of sexual differentiation will be
imperative to understanding maternal programming, because these processes overlap. Just as energy balancing characteristics can be
programmed by perinatal steroid action, they can be similarly affected
during perinatal development by other hormones originating from the
fetus. Some of these hormones respond to the availability of oxidizable
fuels or modulate the availability of those fuels, including leptin (Bouret
et al., 2004b). Animals homozygous for mutations in the gene that encodes leptin (Lepob/Lepob mice) are hyperphagic, obese, and diabetic.
Lepob/Lepob mice lack the spike in leptin secretion that normally occurs
during the rst week after birth of wild type mice, and develop decits
in the hypothalamic neural projections from the ARH to the PVH, DMH,
and LH. When Lepob/Lepob mice are treated with leptin during a critical
window of ARH development (postnatal days 412), the decits in ARH
projections are fully reversed and the obesity is ameliorated (Bouret
et al., 2004b). The same treatment in adult Lepob/Lepob mice fails to affect
ARH projections, suggesting that leptin acts neonatally as a neurotrophic
factor to determine the fate of these particular neural structures involved
in adult energy balance. If the process whereby leptin organizes ARH projections is analogous to the process whereby gonadal hormones organize
the neural substrates for male- and female-typical sex behaviors, then
perinatal leptin surges might render the brain more sensitive to adult effects of leptin, and this effect might be sex-specic. This has not been directly tested to the best of our knowledge. In fact, in the above-mentioned
study, it is not clear whether the subjects were male or female. In the online supplementary material it is specied that males were used in the
control group, but the sex of the experimental animals was not
specied. In a parallel study, males and females were not different, and
were thus combined into age groups in order to characterize the temporal
sequence of development of ARH projections. In another part of the study
aimed at understanding ARH activation in response to leptin treatment,
the sexes were not shown separately (Bouret et al., 2004a).
113
A
Maternal
programming
Sexual
differentiation
D
B
Endocrine
disruptors
114
accommodation. Genetic variability in a suite of ingestive traits was compared in different groups of plant/detritus-eating tadpoles. Broad-sense
heritabilities (amount of total genetic variance) were compared in 1)
tadpoles fed ancestral (plant/detritus) diets, 2) tadpoles fed carnivorous
diets, or 3) tadpoles fed the ancestral diet and treated with exogenous
corticosterone. In the species used as a proxy for the ancestral species,
Scaphiopus couchii, the carnivorous diet and corticosterone treatment
signicantly increase the genetic variance in traits related to ingestion.
Thus, both the new diet and the increase in stress hormones can unmask
genetic variation in a population, presumably allowing transgenerational
changes that would not have occurred otherwise.
Though both treatments increased genetic variation, the nature and
direction of the change in genetic variation differed between these two
treatments. One possibility to explain the difference between the carnivorous diet and the corticosterone treatment is that hormonal effects
differ depending on the energetic or nutritional background. Hormonal
interaction with energy availability might have played a critical role in
rapid population changes over generations (Ledon-Rettig et al., 2010).
If diet changes and glucocorticoids can unmask cryptic genetic
variation in toads, might changes in human diets and exposure to endocrine disruptors over the course of evolution also induce new genetic
variability leading to rapid changes in energy balancing phenotypes?
Can endocrine disruptors acting through glucocorticoid or other receptors also unmask cryptic variation? Alternatively or in addition, have
endocrine disruptors had widespread transgenerational epigenetic
effects that led to rapid population changes in energy balancing phenotypes? It is plausible that endocrine disruptors are altering or guiding
the rate of change in traits related to diabetes and obesity. The startling
implication is that might underlie the sharp increase in the incidence of
obesity and metabolic syndrome, not by acting on adults, but by acting
on the developing offspring, changing gene expression, exposing hidden genetic variation, thereby accelerating the rate of phenotypic
change over generations.
This might also provide a partial explanation for the nding that
laboratory rodents that were switched from traditional laboratory diets
containing high levels of phytoestrogens to a phytoestrogen-free diet become obese (Ruhlen et al., 2008). Until recently, all commercial laboratory
chow diets are produced with soy as the primary ingredient, which contains high levels of phytoestrogens. Scientists interested in the effects of estradiol on various physiological and behavioral traits have recently
switched to phytoestrogen-free diets in order to control for steroid exposure in their experimental and control groups. The unexpected result,
however, was the development of obesity and various reproductive abnormalities in the control animals fed the phytoestrogen-free diets. This phenomenon suggests that, as soy-based laboratory rodent chows have
become the norm, laboratory populations of animals have become adapted
to regular exposure to endocrine disrupting phytoestrogens, and thus,
when experimenters attempt to exercise control of estrogenic exposure
by feeding phytoestrogen-free diets, their animals experience abnormalities related to energy balance and reproduction. The ubiquity of soybased products in standard laboratory chow occurred in a relatively
short time frame (by evolutionary standards), but the phenomenon of
transgenerational epimutations and genetic accommodation provides
a mechanism that might account for these rapid population shifts.
The focus by Ledon-Rettig on genetic variation in characteristics
of the gut may be prescient in that it encompasses new data demonstrating effects of gut ora on energy balance (Turnbaugh et al., 2006).
Endocrine disruptors and perinatal steroids can inuence the favorability
of the gut environment for proliferation of obesogenic versus
obesoresistant microorganisms (Lalles, 2012). Adaptation of laboratory
species to phytoestrogen-containing diets might involve changes in
populations of microorganisms that inhabit the gut and inuence
energy storage and expenditure.
The above considerations are admittedly speculative, but more
importantly, they lead to valuable hypotheses that can be tested
if we merge the concepts of sexual differentiation to the study of
115
Acknowledgments
The authors gratefully acknowledge gures drawn by Jay Alexander,
inspiration from conversations with Jon Levine, and the insightful
comments on the manuscript from Mark I. Friedman, Deborah Clegg,
Samantha Hanna, and Melynda Dalzon. This work was supported by
research grant IOS-1257876 from the National Science Foundation.
References
Akieda-Asai, S., Koda, S., Sugiyama, M., Hasegawa, K., Furuya, M., Miyazato, M., Date, Y.,
2013. Metabolic features of rats resistant to a high-fat diet. Obes. Res. Clin. Pract. 7,
e243e250.
Alexanderson, C., Henningsson, S., Lichtenstein, P., Holmang, A., Eriksson, E., 2011.
Inuence of having a male twin on body mass index and risk for dyslipidemia in
middle-aged and old women. Int. J. Obes. 35, 14661469.
Alleva, E., Brock, J., Brouwer, A., Colburn, T., Fossi, C., Gray, E., Guillette, L., Hauser, P.,
Leatherland, J., MacLusky, N., Mutti, A., Palanza, P., Parmigiani, S., Portereld, S.,
1998. Statement from the work session on environmental endocrine-disrupting
chemicals: Neural, endocrine and behavioural effects. Toxicol. Ind. Health 14, 18.
Armitage, J.A., Khan, I.Y., Taylor, P.D., Nathanielsz, P.W., Poston, L., 2004. Developmental
programming of the metabolic syndrome by maternal nutritional imbalance: how
strong is the evidence from experimental models in mammals? J. Physiol. 561,
355377.
Arnold, A.P., Gorski, R.A., 1984. Gonadal steroid induction of structural sex differences in
the central nervous system. Ann. Rev. Neurosci. 7, 413442.
Arnold, A.P., Chen, X., Itoh, Y., 2012. What a difference an X or Y makes: sex chromosomes,
gene dose, and epigenetics in sexual differentiation. Handb. Exp. Pharmacol. 6788.
Asarian, L., Geary, N., 2013. Sex differences in the physiology of eating. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 305, R1215R1267.
Aschkenasy-Lelu, P., Aschkenasy, A., 1959. Effects of androgens and oestrogens
on the metabolism of proteins and the growth of tissues. World Rev. Nutr. Diet. 1,
2960.
Astrup, A., 2011. The relevance of increased fat oxidation for body-weight management:
metabolic inexibility in the predisposition to weight gain. Obes. Rev. 12, 859865.
Auwerx, J., 1999. PPARgamma, the ultimate thrifty gene. Diabetologia 42, 10331049.
Baillie-Hamilton, P.F., 2002. Chemical toxins: a hypothesis to explain the global obesity
epidemic. J. Altern. Complement. Med. 8, 185192.
Bakker, J., Honda, S., Harada, N., Balthazart, J., 2002. The aromatase knock-out mouse
provides new evidence that estradiol is required during development in the female
for the expression of sociosexual behaviors in adulthood. J. Neurosci. 22, 91049112.
Bakker, J., De Mees, C., Douhard, Q., Balthazart, J., Gabant, P., Szpirer, J., Szpirer, C., 2006.
Alpha-fetoprotein protects the developing female mouse brain from masculinization
and defeminization by estrogens. Nat. Neurosci. 9, 220226.
Balabanic, D., Rupnik, M., Klemencic, A.K., 2011. Negative impact of endocrine-disrupting
compounds on human reproductive health. Reprod. Fertil. Dev. 23, 403416.
Balthazart, J., Levine, J.E., 2014. Endocrine disruptors: a relevant issue for neuroendocrinology also! Front. Neuroendocrinol. 35, 1.
Barker, D.J., 1997. Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 13,
807813.
Barsh, G.S., Schwartz, M.W., 2002. Genetic approaches to studying energy balance:
perception and integration. Nat. Rev. Genet. 3.
Bartoshuk, L.M., 1978. The psychophysics of taste. Am. J. Clin. Nutr. 31, 10681077.
Bell, D.D., Zucker, I., 1971. Sex differences in body weight and eating: organization and activation by gonadal hormones in the rat. Physiol. Behav. 7, 2734.
Berthold, A.A., 1849. Transplantation of testis. Bull. Hist. Med. 16, 4246.
Bjorntorp, P., 1988. The associations between obesity, adipose tissue distribution and
disease. Acta Med. Scand. Suppl. 723, 121134.
Blaschko, S.D., Cunha, G.R., Baskin, L.S., 2012. Molecular mechanisms of external genitalia
development. Differentiation 84, 261268.
Bloor, I.D., Symonds, M.E., 2014. Sexual dimorphism in white and brown adipose tissue
with obesity and inammation. Horm. Behav. 66, 95103.
Blundell, J.E., Cooling, J., 1999. High-fat and low-fat (behavioural) phenotypes: biology or
environment? Proc. Nutr. Soc. 58, 773777.
Blundell, J.E., Cooling, J., 2000. Routes to obesity: phenotypes, food choices and activity. Br.
J. Nutr. 83 (Suppl. 1), S33S38.
Bol, V.V., Delattre, A.I., Reusens, B., Raes, M., Remacle, C., 2009. Forced catch-up growth
after fetal protein restriction alters the adipose tissue gene expression program
leading to obesity in adult mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297,
R291R299.
Bonora, E., 2000. Relationship between regional fat distribution and insulin resistance. Int.
J. Obes. Relat. Metab. Disord. 24 (Suppl. 2), S32S35.
Bonthuis, P.J., Rissman, E.F., 2013. Neural growth hormone implicated in body weight sex
differences. Endocrinology 154, 38263835.
Bordet, F., Mallet, J., Maurice, L., Borrel, S., Venant, A., 1993. Organochlorine pesticide and
PCB congener content of French human milk. Bull. Environ. Contam. Toxicol. 50,
425432.
Bouchard, C., Tremblay, A., 1990. Genetic effects in human energy expenditure components. Int. J. Obes. 14 (Suppl. 1), 4955 (discussion 55-48).
Bouret, S.G., Draper, S.J., Simerly, R.B., 2004a. Formation of projection pathways from the
arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the
neural control of feeding behavior in mice. J. Neurosci. 24, 27972805.
116
Bouret, S.G., Draper, S.J., Simerly, R.B., 2004b. Trophic action of leptin on hypothalamic
neurons that regulate feeding. Science 304, 108110.
Bouret, S.G., 2010. Leptin, nutrition, and the programming of hypothalamic feeding circuits. Nestle Nutr. Workshop Ser. Pediatr. Program 65, 2535 (discussion 3529).
Bowerman, W.W., Giesy, J.P., Best, D.A., Kramer, V.J., 1995. A review of factors affecting
productivity of bald eagles in the Great Lakes region: implications for recovery.
Environ. Health Perspect. 103 (Suppl. 4), 5159.
Briggs, D.I., Andrews, Z.B., 2011. Metabolic status regulates ghrelin function on energy
homeostasis. Neuroendocrinology 93, 4857.
Brinkmann, A.O., 2011. Molecular mechanisms of androgen actiona historical perspective. Methods Mol. Biol. 776, 324.
Brock, O., Baum, M.J., Bakker, J., 2011. The development of female sexual behavior
requires prepubertal estradiol. J. Neurosci. Off. J. Soc. Neurosci. 31, 55745578.
Brown, W.M., Hines, M., Fane, B.A., Breedlove, S.M., 2002. Masculinized nger length
patterns in human males and females with congenital adrenal hyperplasia. Horm.
Behav. 42, 380386.
Bruns, C.M., Baum, S.T., Colman, R.J., Eisner, J.R., Kemnitz, J.W., Weindruch, R., Abbott, D.H.,
2004. Insulin resistance and impaired insulin secretion in prenatally androgenized
male rhesus monkeys. J. Clin. Endocrinol. Metab. 89, 62186223.
Bundred, P., Kitchiner, D., Buchan, I., 2001. Prevalence of overweight and obese children
between 1989 and 1998: population based series of cross sectional studies. BMJ
322, 326328.
Campeld, L.A., Smith, F.J., Guisez, Y., Devos, R., Burn, P., 1995. Recombinant mouse ob
protein: evidence for a peripheral signal linking adiposity and central neural
networks. Science 269, 546549.
Chamorro-Garcia, R., Kirchner, S., Li, X., Janesick, A., Casey, S.C., Chow, C., Blumberg, B.,
2012. Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent
stromal stem cells through a peroxisome proliferator-activated receptor gammaindependent mechanism. Environ. Health Perspect. 120, 984989.
Chamorro-Garcia, R., Sahu, M., Abbey, R.J., Laude, J., Pham, N., Blumberg, B., 2013.
Transgenerational inheritance of increased fat depot size, stem cell reprogramming,
and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in
mice. Environ. Health Perspect. 121, 359366.
Chaput, J.P., Perusse, L., Despres, J.P., Tremblay, A., Bouchard, C., 2014. Findings from the
Quebec family study on the etiology of obesity: genetics and environmental
highlights. Curr. Obes. Rep. 3, 5466.
Chen, X., McClusky, R., Chen, J., Beaven, S.W., Tontonoz, P., Arnold, A.P., Reue, K., 2012. The
number of x chromosomes causes sex differences in adiposity in mice. PLoS Genet. 8,
e1002709.
Chen, X., McClusky, R., Itoh, Y., Reue, K., Arnold, A.P., 2013. X and Y chromosome
complement inuence adiposity and metabolism in mice. Endocrinology 154,
10921104.
Clark, A.R., Belvisi, M.G., 2012. Maps and legends: the quest for dissociated ligands of the
glucocorticoid receptor. Pharmacol. Ther. 134, 5467.
Clarke, I.J., 2001. Sex and season are major determinants of voluntary food intake in
sheep. Reprod. Fertil. Dev. 13, 577582.
Clarke, I.J., Tilbrook, A.J., Turner, A.I., Doughton, B.W., Goding, J.W., 2001. Sex, fat and the
tilt of the earth: effects of sex and season on the feeding response to centrally
administered leptin in sheep. Endocrinology 142, 27252728.
Clegg, D.J., Brown, L.M., Woods, S.C., Benoit, S.C., 2006. Gonadal hormones determine
sensitivity to central leptin and insulin. Diabetes 55, 978987.
Clegg, D.J., Brown, L.M., Zigman, J.M., Kemp, C.J., Strader, A.D., Benoit, S.C., Woods, S.C.,
Mangiaracina, M., Geary, N., 2007. Estradiol-dependent decrease in the orexigenic
potency of ghrelin in female rats. Diabetes 56, 10511058.
Colborn, T., 1991. Epidemiology of Great Lakes bald eagles. J. Toxicol. Environ. Health 33,
395453.
Colborn, T., vom Saal, F.S., Soto, A.M., 1993. Developmental effects of endocrine-disrupting
chemicals in wildlife and humans. Environ. Health Perspect. 101, 378384.
Colborn, T., Dumanoski, D., Myers, J.P., 1997. Our Stolen Future. Penguin Books U.S.A.
Incorporated, New York, New York, U.S.A.
Crews, D., Gore, A.C., 2011. Life imprints: living in a contaminated world. Environ. Health
Perspect. 119, 12081210.
Crews, D., Willingham, E., Skipper, J.K., 2000. Endocrine disruptors: present issues, future
directions. Q. Rev. Biol. 75, 243260.
Crowley, M.A., Smart, J.L., Rubinstein, M., Cerdans, M.G., Diano, S., Horvath, T.L., Cone, R.D.,
Low, M.J., 2001. Leptin activates anorexigenic POMC neurons through a neural
network in the arcuate nucleus. Nature 411, 480484.
Culbert, K.M., Breedlove, S.M., Sisk, C.L., Burt, S.A., Klump, K.L., 2013. The emergence of sex
differences in risk for disordered eating attitudes during puberty: a role for prenatal
testosterone exposure. J. Abnorm. Psychol. 122, 420432.
Davidson, J.M., Rodgers, C.H., Smith, E.R., Bloch, G.J., 1968. Stimulation of female sex
behavior in adrenalectomized rats with estrogen alone. Endocrinology 82, 193195.
de Oliveira, J.C., Grassiolli, S., Gravena, C., de Mathias, P.C., 2012. Early postnatal lowprotein nutrition, metabolic programming and the autonomic nervous system in
adult life. Nutr. Metab. 9, 80.
Demissie, M., Lazic, M., Foecking, E.M., Aird, F., Dunaif, A., Levine, J.E., 2008. Transient
prenatal androgen exposure produces metabolic syndrome in adult female rats.
Am. J. Physiol. Endocrinol. Metab. 295, E262E268.
Desai, M., Gayle, D., Babu, J., Ross, M.G., 2005. Programmed obesity in intrauterine
growth-restricted newborns: modulation by newborn nutrition. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 288, R91R96.
Desai, M., Babu, J., Ross, M.G., 2007. Programmed metabolic syndrome: prenatal undernutrition and postweaning overnutrition. Am. J. Physiol. Regul. Integr. Comp. Physiol.
293, R2306R2314.
Despres, J.P., 1993. Abdominal obesity as important component of insulin-resistance
syndrome. Nutrition 9, 452459.
Eckel, L.A., 2011. The ovarian hormone estradiol plays a crucial role in the control of food
intake in females. Physiol. Behav. 104, 517524.
Eisner, J.R., Dumesic, D.A., Kemnitz, J.W., Colman, R.J., Abbott, D.H., 2003. Increased
adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obes. Res. 11, 279286.
Elango, A., Shepherd, B., Chen, T.T., 2006. Effects of endocrine disrupters on the expression
of growth hormone and prolactin mRNA in the rainbow trout pituitary. Gen. Comp.
Endocrinol. 145, 116127.
Eriksson, J.G., Forsen, T., Tuomilehto, J., Winter, P.D., Osmond, C., Barker, D.J., 1999. Catchup growth in childhood and death from coronary heart disease: longitudinal study.
BMJ 318, 427431.
Farooqi, S., Rau, H., Whitehead, J., O'Rahilly, S., 1998. ob gene mutations and human
obesity. Proc. Nutr. Soc. 57, 471475.
Feder, H.H., Phoenix, C.H., Young, W.C., 1966. Suppression of feminine behaviour by
administration of testosterone propionate to neonatal rats. J. Endocrinol. 34, 131132.
Fink, B., Neave, N., Manning, J.T., 2003. Second to fourth digit ratio, body mass index,
waist-to-hip ratio, and waist-to-chest ratio: their relationships in heterosexual men
and women. Ann. Hum. Biol. 30, 728738.
Flegal, K.M., Carroll, M.D., Kuczmarski, R.J., Johnson, C.L., 1998. Overweight and obesity in
the United States: prevalence and trends, 19601994. Int. J. Obes. Relat. Metab.
Disord. 22, 3947.
Flegal, K.M., Carroll, M.D., Ogden, C.L., Johnson, C.L., 2002. Prevalence and trends in obesity
among US adults, 19992000. JAMA 288, 17231727.
Flegal, K.M., Carroll, M.D., Ogden, C.L., Curtin, L.R., 2010. Prevalence and trends in obesity
among US adults, 19992008. JAMA 303, 235241.
Forsdahl, A., 1978. Living conditions in childhood and subsequent development of risk
factors for arteriosclerotic heart disease. The Cardiovascular Survey in Finnmark
197475. J. Epidemiol. Community Health 32, 3437.
Friedman, M.I., 1990. Body fat and the metabolic control of food intake. Int. J. Obes. 14
(Suppl. 3), 5366 (discussion 66-57).
Friedman, M.I., 1998. Fuel partitioning and food intake. Am. J. Clin. Nutr. 67, 513S518S.
Friedman, M.I., 2008. Food intake: control, regulation and the illusion of dysregulation. In:
Harris, R.B., Mattes, R. (Eds.), Appetite and Food Intake: Behavioral and Physiological
Considerations. CRC Press, Boca Raton, Florida, USA, pp. 119.
Frye, C.A., Bo, E., Calamandrei, G., Calza, L., Dessi-Fulgheri, F., Fernandez, M., Fusani, L.,
Kah, O., Kajta, M., Le Page, Y., Patisaul, H.B., Venerosi, A., Wojtowicz, A.K.,
Panzica, G.C., 2012. Endocrine disrupters: a review of some sources, effects, and
mechanisms of actions on behaviour and neuroendocrine systems. J.
Neuroendocrinol. 24, 144159.
Gao, Q., Mezei, G., Nie, Y., Rao, Y., Choi, C.S., Bechmann, I., Leranth, C., Toran-Allerand, D.,
Priest, C.A., Roberts, J.L., Gao, X.B., Mobbs, C., Shulman, G.I., Diano, S., Horvath, T.L.,
2007. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin
cells and Stat3 signaling in obese animals. Nat. Med. 13, 8994.
Garver, W.S., Newman, S.B., Gonzales-Pacheco, D.M., Castillo, J.J., Jelinek, D., Heidenreich,
R.A., Orlando, R.A., 2013. The genetics of childhood obesity and interaction with
dietary macronutrients. Genes Nutr. 8, 271287.
Gatford, K.L., Egan, A.R., Clarke, I.J., Owens, P.C., 1998. Sexual dimorphism of the
somatotrophic axis. J. Endocrinol. 157, 373389.
Geary, N., Asarian, L., Korach, K.S., Pfaff, D.W., Ogawa, S., 2001. Decits in E2-dependent
control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice.
Endocrinology 142, 47514757.
Gentry, R.T., Wade, G.N., 1976. Sex differences in sensitivity of food intake, body weight,
and running-wheel activity to ovarian steroids in rats. J. Comp. Physiol. Psychol. 90,
747754.
German, A.J., 2006. The growing problem of obesity in dogs and cats. J. Nutr. 136,
1940S1946S.
Gillum, R.F., 1987. The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors
in men and women aged 1879 years. J Chron. Dis. 40, 421428.
Gobrogge, K.L., Breedlove, S.M., Klump, K.L., 2008. Genetic and environmental inuences
on 2D:4D nger length ratios: a study of monozygotic and dizygotic male and female
twins. Arch. Sex. Behav. 37, 112118.
Gore, A.C., 2008. Developmental programming and endocrine disruptor effects on
reproductive neuroendocrine systems. Front. Neuroendocrinol. 29, 358374.
Gore, A.C., 2010. Neuroendocrine targets of endocrine disruptors. Horm. (Athens) 9,
1627.
Gore, A.C., Patisaul, H.B., 2010. Neuroendocrine disruption: historical roots, current
progress, questions for the future. Front. Neuroendocrinol. 31, 395399.
Gore, A.C., Balthazart, J., Bikle, D., Carpenter, D.O., Crews, D., Czernichow, P.,
Diamanti-Kandarakis, E., Dores, R.M., Grattan, D., Hof, P.R., Hollenberg, A.N.,
Lange, C., Lee, A.V., Levine, J.E., Millar, R.P., Nelson, R.J., Porta, M., Poth, M.,
Power, D.M., Prins, G.S., Ridgway, E.C., Rissman, E.F., Romijn, J.A., Sawchenko, P.E.,
Sly, P.D., Soder, O., Taylor, H.S., Tena-Sempere, M., Vaudry, H., Wallen, K., Wang, Z.,
Wartofsky, L., Watson, C.S., 2014. Reprint of: policy decisions on endocrine disruptors
should be based on science across disciplines: a response to Dietrich et al. Horm.
Behav. 65, 190193.
Grady, K.L., Phoenix, C.H., Young, W.C., 1965. Role of the developing rat testis in differentiation of the neural tissues mediating mating behavior. J. Comp. Physiol. Psychol. 59,
176182.
Grill, H.J., 2010. Leptin and the systems neuroscience of meal size control. Front.
Neuroendocrinol. 31, 6178.
Grill, H.J., Hayes, M.R., 2009. The nucleus tractus solitarius: a portal for visceral afferent
signal processing, energy status assessment and integration of their combined effects
on food intake. Int. J. Obes. 33 (Suppl. 1), S11S15.
Grun, F., Blumberg, B., 2006. Environmental obesogens: organotins and endocrine
disruption via nuclear receptor signaling. Endocrinology 147, S50S55.
117
Lenz, K.M., Nugent, B.M., McCarthy, M.M., 2012. Sexual differentiation of the rodent brain:
dogma and beyond. Front. Neurosci. 6, 26.
Levin, B.E., 2009. Synergy of nature and nurture in the development of childhood obesity.
Int. J. Obes. 33 (Suppl. 1), S53S56.
Levin, B.E., Triscari, J., Hogan, S., Sullivan, A.C., 1987. Resistance to diet-induced obesity:
food intake, pancreatic sympathetic tone, and insulin. Am. J. Physiol. 252, R471R478.
Liu, L., Ma, C., Wen, Z., Zhang, L., Zhang, Z., Jia, L., 2012. Effect of bisphenol A exposure
during early development on body weight and glucose metabolism of female lial
rats. Wei Sheng Yan Jiu 41, 543545 (550).
Lovejoy, J.C., Champagne, C.M., de Jonge, L., Xie, H., Smith, S.R., 2008. Increased visceral fat
and decreased energy expenditure during the menopausal transition. Int. J. Obes. 32,
949958.
Lumey, L.H., Stein, A.D., 1997. Offspring birth weights after maternal intrauterine undernutrition: a comparison within sibships. Am. J. Epidemiol. 146, 810819.
Lundgren, H., Bengtsson, C., Blohme, G., Lapidus, L., Sjostrom, L., 1989. Adiposity and
adipose tissue distribution in relation to incidence of diabetes in women: results
from a prospective population study in Gothenburg, Sweden. Int. J. Obes. 13, 413423.
Lustig, R.H., 2006. Childhood obesity: behavioral aberration or biochemical drive?
Reinterpreting the rst law of thermodynamics. Nat. Clin. Pract. Endocrinol. Metab.
2, 447458.
Mackay, H., Patterson, Z.R., Khazall, R., Patel, S., Tsirlin, D., Abizaid, A., 2013. Organizational
effects of perinatal exposure to bisphenol-A and diethylstilbestrol on arcuate nucleus
circuitry controlling food intake and energy expenditure in male and female CD-1
mice. Endocrinology 154, 14651475.
MacLusky, N.J., Naftolin, F., 1981. Sexual differentiation of the central nervous system.
Science 211, 12941302.
Macor, C., Ruggeri, A., Mazzonetto, P., Federspil, G., Cobelli, C., Vettor, R., 1997. Visceral
adipose tissue impairs insulin secretion and insulin sensitivity but not energy
expenditure in obesity. Metabolism 46, 123129.
Macotela, Y., Boucher, J., Tran, T.T., Kahn, C.R., 2009. Sex and depot differences in
adipocyte insulin sensitivity and glucose metabolism. Diabetes 58, 803812.
Madsen, A.N., Hansen, G., Paulsen, S.J., Lykkegaard, K., Tang-Christensen, M., Hansen,
H.S., Levin, B.E., Larsen, P.J., Knudsen, L.B., Fosgerau, K., Vrang, N., 2010. Longterm characterization of the diet-induced obese and diet-resistant rat model: a
polygenetic rat model mimicking the human obesity syndrome. J. Endocrinol.
206, 287296.
Manikkam, M., Crespi, E.J., Doop, D.D., Herkimer, C., Lee, J.S., Yu, S., Brown, M.B., Foster, D.L.,
Padmanabhan, V., 2004. Fetal programming: prenatal testosterone excess leads to
fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology
145, 790798.
Manikkam, M., Tracey, R., Guerrero-Bosagna, C., Skinner, M.K., 2013. Plastics derived
endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational
inheritance of obesity, reproductive disease and sperm epimutations. PLoS One 8, e55387.
Marin, P., Bjorntorp, P., 1993. Endocrinemetabolic pattern and adipose tissue distribution. Horm. Res. 39 (Suppl. 3), 8185.
Marmugi, A., Ducheix, S., Lasserre, F., Polizzi, A., Paris, A., Priymenko, N., Bertrand-Michel,
J., Pineau, T., Guillou, H., Martin, P.G., Mselli-Lakhal, L., 2012. Low doses of bisphenol A
induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 55, 395407.
Martinez, J.A., Corbalan, M.S., Sanchez-Villegas, A., Forga, L., Marti, A., MartinezGonzalez, M.A., 2003. Obesity risk is associated with carbohydrate intake in
women carrying the Gln27Glu beta2-adrenoceptor polymorphism. J. Nutr. 133,
25492554.
Masumo, H., Kidani, T., Sekiya, K., Sakayama, K., Shiosaka, T., Yamamoto, H., Honda, K.,
2002. Bisphenol A in combination with insulin can accelerate the conversion of
3T3L1 broblasts to adipocytes. J. Lipid Res. 43, 676684.
Masuno, H., Kidani, T., Sekiya, K., Sakayama, K., Shiosaka, T., Yamamoto, H., Honda, K.,
2002. Bisphenol A in combination with insulin can accelerate the conversion of
3T3-L1 broblasts to adipocytes. J. Lipid Res. 43, 676684.
McMillen, I.C., Adam, C.L., Muhlhausler, B.S., 2005. Early origins of obesity: programming
the appetite regulatory system. J. Physiol. 565, 917.
McNay, D.E., Briancon, N., Kokoeva, M.V., Maratos-Flier, E., Flier, J.S., 2012. Remodeling of
the arcuate nucleus energy-balance circuit is inhibited in obese mice. J. Clin. Invest.
122, 142152.
Morris, J.A., Jordan, C.L., Breedlove, S.M., 2004. Sexual differentiation of the vertebrate
nervous system. Nat. Neurosci. 7, 10341039.
Muramatsu, M., Inoue, S., 2000. Estrogen receptors: how do they control reproductive and
nonreproductive functions? Biochem. Biophys. Res. Commun. 270, 110.
Mutch, D.M., Pers, T.H., Temanni, M.R., Pelloux, V., Marquez-Quinones, A., Holst, C.,
Martinez, J.A., Babalis, D., van Baak, M.A., Handjieva-Darlenska, T., Walker, C.G.,
Astrup, A., Saris, W.H., Langin, D., Viguerie, N., Zucker, J.D., Clement, K., 2011. A
distinct adipose tissue gene expression response to caloric restriction predicts 6-mo
weight maintenance in obese subjects. Am. J. Clin. Nutr. 94, 13991409.
Nadal, A., 2013. Obesity: fat from plastics? Linking bisphenol A exposure and obesity. Nat.
Rev. Endocrinol. 9, 910.
Negri-Cesi, P., Colciago, A., Celotti, F., Motta, M., 2004. Sexual differentiation of the brain:
role of testosterone and its active metabolites. Endocrinol. Invest. 27, 120127.
Negri-Cesi, P., Colciago, A., Pravettoni, A., Casati, L., Conti, L., Celotti, F., 2008. Sexual
differentiation of the rodent hypothalamus: hormonal and environmental inuences.
J. Steroid Biochem. Mol. Biol. 109, 294299.
Newbold, R.R., Padilla-Banks, E., Snyder, R.J., Jefferson, W.N., 2005. Developmental
exposure to estrogenic compounds and obesity. Birth Defects Res. A Clin. Mol. Teratol.
73, 478480.
Nohara, K., Zhang, Y., Waraich, R.S., Laque, A., Tiano, J.P., Tong, J., Munzberg, H., MauvaisJarvis, F., 2011. Early-life exposure to testosterone programs the hypothalamic
melanocortin system. Endocrinology 152, 16611669.
118
Nordkap, L., Joensen, U.N., Blomberg Jensen, M., Jorgensen, N., 2012. Regional differences
and temporal trends in male reproductive health disorders: semen quality may be a
sensitive marker of environmental exposures. Mol. Cell. Endocrinol. 355, 221230.
Novak, C.M., Kotz, C.M., Levine, J.A., 2006. Central orexin sensitivity, physical activity, and
obesity in diet-induced obese and diet-resistant rats. Am. J. Physiol. Endocrinol.
Metab. 290, E396E403.
Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, K.M., 2006.
Prevalence of overweight and obesity in the United States, 19992004. JAMA 295,
15491555.
Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., 2013. Prevalence of obesity among adults:
United States, 20112012. NCHS Data Brief. 18.
Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., 2014. Prevalence of childhood and adult
obesity in the United States, 20112012. JAMA 311, 806814.
Ogden, C.L., Troiano, R.P., Briefel, R.R., Kuczmarski, R.J., Flegal, K.M., Johnson, C.L., 1997.
Prevalence of overweight among preschool children in the United States, 1971
through 1994. Pediatrics 99, E1.
Ogden, C.L., Yanovski, S.Z., Carroll, M.D., Flegal, K.M., 2007. The epidemiology of obesity.
Gastroenterology 132, 20872102.
Oken, E., Gillman, M.W., 2003. Fetal origins of obesity. Obes. Res. 11, 496506.
Ottinger, M.A., Abdelnabi, M.A., Henry, P., McGary, S., Thompson, N., Wu, J.M., 2001.
Neuroendocrine and behavioral implications of endocrine disrupting chemicals in
quail. Horm. Behav. 40, 234247.
Ottinger, M.A., Dean, K.M., 2011. Neuroendocrine impacts of endocrine-disrupting
chemicals in birds: life stage and species sensitivities. J. Toxicol. Environ Health B
Crit. Rev. 14, 413422.
Ottinger, M.A., Lavoie, E., Thompson, N., Barton, A., Whitehouse, K., Barton, M., Abdelnabi,
M., Quinn Jr., M., Panzica, G., Viglietti-Panzica, C., 2008. Neuroendocrine and
behavioral effects of embryonic exposure to endocrine disrupting chemicals in
birds. Brain Res. Rev. 57, 376385.
Ottinger, M.A., Quinn Jr., M.J., Lavoie, E., Abdelnabi, M.A., Thompson, N., Hazelton, J.L., Wu,
J.M., Beavers, J., Jaber, M., 2005. Consequences of endocrine disrupting chemicals
on reproductive endocrine function in birds: establishing reliable end points of
exposure. Domest. Anim. Endocrinol. 29, 411419.
Pasquali, R., 2006. Obesity and androgens: facts and perspectives. Fertil. Steril. 85, 13191340.
Patisaul, H.B., 2005. Phytoestrogen action in the adult and developing brain. J.
Neuroendocrinol. 17, 5764.
Patisaul, H.B., 2013. Effects of environmental endocrine disruptors and phytoestrogens
on the kisspeptin system. Adv. Exp. Med. Biol. 784, 455479.
Patisaul, H.B., Polston, E.K., 2008. Inuence of endocrine active compounds on the
developing rodent brain. Brain Res. Rev. 57, 352362.
Pelleymounter, M.A., Cullen, M.J., Baker, M.B., Hecht, R., Winters, D., Boone, T., Collins, F.,
1995. Effects of the obese gene product on body weight regulation in ob/ob mice.
Science 269, 540543.
Pfaff, D.W., Zigmond, R.E., 1971. Neonatal androgen effects on sexual and non-sexual
behavior of adult rats tested under various hormone regimes. Neuroendocrinology
7, 129145.
Phoenix, C.H., Chambers, K.C., 1982. Sexual behavior in adult gonadectomized female
pseudohermaphrodite, female, and male rhesus macaques (Macaca mulatta) treated
with estradiol benzoate and testosterone propionate. J. Comp. Physiol. Psychol. 96,
823833.
Phoenix, C.H., Goy, R.W., Gerall, A.A., Young, W.C., 1959. Organizing action of prenatally
administered testosterone propionate on the tissues mediating mating behavior in
the female guinea pig. Endocrinology 65, 369382.
Phoenix, C.H., Jensen, J.N., Chambers, K.C., 1983. Female sexual behavior displayed by
androgenized female rhesus macaques. Horm. Behav. 17, 146151.
Pierce, W.D., Diane, A., Heth, C.D., Russell, J.C., Proctor, S.D., 2010. Evolution and obesity:
resistance of obese-prone rats to a challenge of food restriction and wheel running.
Int. J. Obes. 34, 589592.
Pinto, S., Roseberry, A.G., Liu, H., Diano, S., Shanabrough, M., Cai, X., Friedman, J.M.,
Horvath, T.L., 2004. Rapid rewiring of arcuate nucleus feeding circuits by leptin.
Science 304, 110115.
Polyzos, S.A., Kountouras, J., Deretzi, G., Zavos, C., Mantzoros, C.S., 2012. The emerging role
of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating
nonalcoholic fatty liver disease. Curr. Mol. Med. 12, 6882.
Power, M.L., Schulkin, J., 2008. Sex differences in fat storage, fat metabolism, and the
health risks from obesity: possible evolutionary origins. Br. J. Nutr. 99, 931940.
Prutkin, J., Fisher, E.M., Etter, L., Fast, K., Gardner, E., Lucchina, L.A., Snyder, D.J., Tie, K.,
Weiffenbach, J., Bartoshuk, L.M., 2000. Genetic variation and inferences about
perceived taste intensity in mice and men. Physiol. Behav. 69, 161173.
Raffan, E., 2013. The big problem: battling companion animal obesity. Vet. Rec. 173,
287291.
Rankinen, T., Zuberi, A., Chagnon, Y.C., Weisnagel, S.J., Argyropoulos, G., Walts, B., Perusse,
L., Bouchard, C., 2006. The human obesity gene map: the 2005 update. Obesity 14,
529644.
Ravelli, G.P., Stein, Z.A., Susser, M.W., 1976. Obesity in young men after famine exposure
in utero and early infancy. N. Engl. J. Med. 295, 349353.
Rebuffe-Scrive, M., Enk, L., Crona, N., Lonnroth, P., Abrahamsson, L., Smith, U., Bjorntorp, P.,
1985. Fat cell metabolism in different regions in women. Effect of menstrual cycle,
pregnancy, and lactation. J. Clin. Invest. 75, 19731976.
Recabarren, S.E., Padmanabhan, V., Codner, E., Lobos, A., Duran, C., Vidal, M., Foster, D.L.,
Sir-Petermann, T., 2005. Postnatal developmental consequences of altered insulin
sensitivity in female sheep treated prenatally with testosterone. Am. J. Physiol.
Endocrinol. Metab. 289, E801E806.
Reddy, J.K., Hashimoto, T., 2001. Peroxisomal beta-oxidation and peroxisome
proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev.
Nutr. 21, 193230.
Redonnet, A., Groubet, R., Noel-Suberville, C., Bonilla, S., Martinez, A., Higueret, P., 2001.
Exposure to an obesity-inducing diet early affects the pattern of expression of
peroxisome proliferator, retinoic acid, and triiodothyronine nuclear receptors in the
rat. Metab. Clin. Exp. 50, 11611167.
Remage-Healey, L., Saldanha, C.J., Schlinger, B.A., 2011. Estradiol synthesis and action at
the synapse: evidence for synaptocrine signaling. Front. Endocrinol. (Lausanne) 2,
28.
Ronn, M., Kullberg, J., Karlsson, H., Berglund, J., Malmberg, F., Orberg, J., Lind, L., Ahlstrom,
H., Lind, P.M., 2013. Bisphenol A exposure increases liver fat in juvenile fructose-fed
Fischer 344 rats. Toxicology 303, 125132.
Ross, M.G., Desai, M., 2005. Gestational programming: population survival effects of
drought and famine during pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol.
288, R25R33.
Ruhlen, R.L., Howdeshell, K.L., Mao, J., Taylor, J.A., Bronson, F.H., Newbold, R.R., Welshons,
W.V., vom Saal, F.S., 2008. Low phytoestrogen levels in feed increase fetal serum
estradiol resulting in the fetal estrogenization syndrome and obesity in CD-1
mice. Environ. Health Perspect. 116, 322328.
Sakurai, K., Kawazuma, M., Adachi, T., Harigaya, T., Saito, Y., Hashimoto, N., Mori, C., 2004.
Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br. J.
Pharmacol. 141, 209214.
Saldanha, C.J., Remage-Healey, L., Schlinger, B.A., 2011. Synaptocrine signaling: steroid
synthesis and action at the synapse. Endocr. Rev. 32, 532549.
Sandoval, D.A., Ryan, K.K., de Kloet, A.D., Woods, S.C., Seeley, R.J., 2012. Female rats are
relatively more sensitive to reduced lipid versus reduced carbohydrate availability.
Nutr. Diabetes 2, e27.
Schemmel, R., Mickelsen, O., Gill, J.L., 1970. Dietary obesity in rats: body weight and body
fat accretion in seven strains of rats. J. Nutr. 100, 10411048.
Schmidt, S.L., Kealey, E.H., Horton, T.J., VonKaenel, S., Bessesen, D.H., 2013. The effects of
short-term overfeeding on energy expenditure and nutrient oxidation in obesityprone and obesity-resistant individuals. Int. J. Obes. 37, 11921197.
Schneider, J.E., Klingerman, C.M., Abdulhay, A., 2012. Sense and nonsense in metabolic
control of reproduction. Front. Endocrinol. 3 (3), 26. http://dx.doi.org/10.3389/
fendo.2012.00026.
Schneider, J.E., Wise, J.D., Benton, N.A., Brozek, J.M., Keen-Rhinehart, E., 2013. When do we
eat? Ingestive behavior, survival, and reproductive success. Horm. Behav. 64,
702728.
Schwartz, M.W., Porte Jr., D., 2005. Diabetes, obesity, and the brain. Science 307, 375379.
Shankar, A., Teppala, S., Sabanayagam, C., 2012. Urinary bisphenol a levels and measures
of obesity: results from the National Health and Nutrition Examination Survey
20032008. ISRN Endocrinol. 2012, 965243.
Sheppard, K.M., Padmanabhan, V., Coolen, L.M., Lehman, M.N., 2011. Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe. J.
Neuroendocrinol. 23, 401411.
Shi, H., Clegg, D.J., 2009. Sex differences in the regulation of body weight. Physiol. Behav.
97, 199204.
Shi, H., Seeley, R.J., Clegg, D.J., 2009. Sexual differences in the control of energy homeostasis.
Front. Neuroendocrinol. 30, 396404.
Shi, H., Strader, A.D., Sorrell, J.E., Chambers, J.B., Woods, S.C., Seeley, R.J., 2008. Sexually
different actions of leptin in proopiomelanocortin neurons to regulate glucose
homeostasis. Am. J. Physiol. Endocrinol. Metab. 294, E630E639.
Siegel, L.I., Nunez, A.A., Wade, G.N., 1981. Effects of androgens on dietary self-selection
and carcass composition in male rats. J. Comp. Physiol. Psychol. 95, 529539.
Simonich, S.L., Hites, R.A., 1995. Global distribution of persistent organochlorine
compounds. Science 269, 18511854.
Singh, D., 1993. Adaptive signicance of female physical attractiveness: role of waist-tohip ratio. J. Pers. Soc. Psychol. 65, 293307.
Singh, D., 1994a. Body fat distribution and perception of desirable female body shape by
young black men and women. Int. J. Eat. Disord. 16, 289294.
Singh, D., 1994b. Ideal female body shape: role of body weight and waist-to-hip ratio. Int.
J. Eat. Disord. 16, 283288.
Singh, D., 1994c. Waist-to-hip ratio and judgment of attractiveness and healthiness of
female gures by male and female physicians. Int. J. Obes. Relat. Metab. Disord. 18,
731737.
Singh, D., 2002. Review. Female mate value at a glance: relationship of waist-to-hip
ratio to health, fecundity and attractiveness. Neuro. Endocrinol. Lett. 23 (Suppl.
4), 8191.
Skinner, M.K., Manikkam, M., Guerrero-Bosagna, C., 2011. Epigenetic transgenerational
actions of endocrine disruptors. Reprod. Toxicol. 31, 337343.
Skinner, M.K., Manikkam, M., Tracey, R., Guerrero-Bosagna, C., Haque, M., Nilsson, E.E.,
2013. Ancestral dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of obesity. BMC Med. 11, 228.
Speakman, J.R., 2006. Thrifty genes for obesity and the metabolic syndrometime to call
off the search? Diabetes Vasc. Dis. Res. 3, 711.
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., Fruchart, J.C., 1998.
Mechanism of action of brates on lipid and lipoprotein metabolism. Circulation 98,
20882093.
Steckler, T.L., Herkimer, C., Dumesic, D.A., Padmanabhan, V., 2009. Developmental programming: excess weight gain amplies the effects of prenatal testosterone excess
on reproductive cyclicityimplication for polycystic ovary syndrome. Endocrinology
150, 14561465.
Sullivan, E.L., Nousen, E.K., Chamlou, K.A., 2014. Maternal high fat diet consumption
during the perinatal period programs offspring behavior. Physiol. Behav. 123,
236242.
Swithers, S.E., McCurley, M., Hamilton, E., Doeringer, A., 2008. Inuence of ovarian
hormones on development of ingestive responding to alterations in fatty acid oxidation in female rats. Horm. Behav. 54, 471477.
119